BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23694985)

  • 1. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.
    Kim CH; Soslow RA; Park KJ; Barber EL; Khoury-Collado F; Barlin JN; Sonoda Y; Hensley ML; Barakat RR; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Jun; 23(5):964-70. PubMed ID: 23694985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
    Kim CH; Khoury-Collado F; Barber EL; Soslow RA; Makker V; Leitao MM; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2013 Dec; 131(3):714-9. PubMed ID: 24099838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and clinical significance of the micrometastases in the sentinel lymph nodes during surgical staging for early endometrial cancer.
    Ferraioli D; Chopin N; Beurrier F; Carrabin N; Buenerd A; Mathevet P
    Int J Gynecol Cancer; 2015 May; 25(4):673-80. PubMed ID: 25902281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
    Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
    Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regarding: "pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging".
    Buda A; Guerra L; Signorelli M
    Int J Gynecol Cancer; 2014 Jul; 24(6):964-5. PubMed ID: 24978705
    [No Abstract]   [Full Text] [Related]  

  • 6. Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC).
    Desai PH; Hughes P; Tobias DH; Tchabo N; Heller PB; Dise C; Slomovitz BM
    Gynecol Oncol; 2014 Nov; 135(2):196-200. PubMed ID: 25175452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastaging of Sentinel Lymph Nodes in Endometrial Carcinoma According to Use of 2 Different Methods.
    Euscher E; Sui D; Soliman P; Westin S; Ramalingam P; Bassett R; Malpica A
    Int J Gynecol Pathol; 2018 May; 37(3):242-251. PubMed ID: 28700425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients.
    Kosťun J; Pešta M; Sláma J; Slunéčko R; Vlasák P; Bouda J; Novotný Z; Topolčan O; Kučera R; Kulda V; Houfková K; Berezovskiy D; Bartáková A; Presl J
    J Surg Oncol; 2019 Mar; 119(3):361-369. PubMed ID: 30508294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
    De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
    Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.
    St Clair CM; Eriksson AG; Ducie JA; Jewell EL; Alektiar KM; Hensley ML; Soslow RA; Abu-Rustum NR; Leitao MM
    Ann Surg Oncol; 2016 May; 23(5):1653-9. PubMed ID: 26714954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer.
    Koskas M; Chereau E; Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Luton D; Rouzier R; Daraï E
    Br J Cancer; 2013 Apr; 108(6):1267-72. PubMed ID: 23481184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Volume Lymph Node Metastases in Endometrial Carcinoma.
    Clinton LK; Kondo J; Carney ME; Tauchi-Nishi P; Terada K; Shimizu D
    Int J Gynecol Cancer; 2017 Jul; 27(6):1165-1170. PubMed ID: 28604450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma.
    Naaman Y; Pinkas L; Roitman S; Ikher S; Oustinov N; Vaisbuch E; Yachnin A; Ben-Arie A
    Ann Surg Oncol; 2016 Feb; 23(2):450-5. PubMed ID: 26438438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer.
    Chiang S; Tessier-Cloutier B; Klein E; Ardon O; Mueller JJ; Leitao MM; Abu-Rustum NR; Ellenson LH
    Int J Gynecol Cancer; 2024 May; 34(5):681-688. PubMed ID: 38388180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.